| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.1M | -5.0% |
| Cost of Revenue | $13.9M | +3.6% |
| Gross Profit | $2.1M | -38.3% |
| R&D Expense | $1.5M | -26.5% |
| SG&A Expense | $4.7M | +54.0% |
| Operating Income | -$5.5M | -78.6% |
| Interest Expense | $58K | -3.3% |
| Net Income | -$5.6M | -294.9% |
| EPS (Basic) | -$0.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $211K | -95.9% |
| Accounts Receivable | $2.2M | -47.4% |
| Inventory | $15.5M | +71.5% |
| Current Assets | $23.3M | -7.3% |
| Total Assets | $24.2M | -11.0% |
| Current Liabilities | $6.0M | +75.3% |
| Long-term Debt | $268K | -47.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | +30.6% |
| Capital Expenditures | $25K | -64.8% |
| Investing Cash Flow | -$25K | +64.8% |
| Financing Cash Flow | $1.6M | -87.3% |
| Free Cash Flow | -$6.5M | +30.9% |
| -290.9% |
| Total Liabilities |
| $6.0M |
| +52.8% |
| Stockholders' Equity | $18.2M | -21.8% |